Devonian Health Group Inc. (TSXV:GSD)
Canada · Delayed Price · Currency is CAD 8.14
-1.11 (-12.00%)
At close: Jun 30, 2026
Devonian Health Group Market Cap
Devonian Health Group has a market cap or net worth of CAD 22.64 million as of July 1, 2026. Its market cap has increased by 23.42% in one year.
Market Cap
22.64M
Enterprise Value
22.06M
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.14
Market Cap Chart
Since May 19, 2017, Devonian Health Group's market cap has decreased from 1.44B to 22.64M, a decrease of -98.43%. That is a compound annual growth rate of -36.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 22.64M | -28.21% |
| Dec 24, 2025 | 31.53M | 32.95% |
| Dec 30, 2024 | 23.72M | 11.47% |
| Dec 21, 2023 | 21.28M | -52.33% |
| Dec 21, 2022 | 44.63M | -94.11% |
| Dec 31, 2021 | 758.36M | 359.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MedMira | 49.12M |
| Microbix Biosystems | 40.64M |
| Defence Therapeutics | 37.89M |
| BriaCell Therapeutics | 37.84M |
| Medicenna Therapeutics | 37.38M |
| Quantum BioPharma | 34.30M |
| Resverlogix | 30.95M |
| Sharp Therapeutics | 30.08M |